Emilia Javorsky joins the podcast to discuss AI-driven power concentration and how we might mitigate it. We also discuss optimism, utopia, and cultural experimentation.
Peter Wildeford discusses methods for forecasting AI progress and why he sees AI as neither a bubble nor a normal technology, covering economic effects, national security, cyber capabilities, robotics, export controls, and prediction markets.
Physician-scientist Emilia Javorsky argues that curing cancer is limited more by biology’s complexity, data quality, and incentives than by intelligence, and explores realistic uses of AI in drug development, trials, and reducing medical bureaucracy.
Emilia Javorsky explores how AI can realistically aid cancer research, where current hype exceeds evidence, and what changes researchers, policymakers, and funders must make to turn AI advances into real clinical impact.
